NCT02014129View on ClinicalTrials.gov

A Study of LY2835219 in Japanese Participants With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 18, 2013

Primary Completion Date

April 1, 2015

Study Completion Date

August 21, 2019

Conditions
Neoplasm MetastasisLymphoma
Interventions
DRUG

LY2835219

Administered orally

Trial Locations (1)

104-0045

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician., Tokyo

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02014129 - A Study of LY2835219 in Japanese Participants With Advanced Cancer | Biotech Hunter | Biotech Hunter